Fintel reports that on April 1, 2025, William Blair upgraded their outlook for Nayax (NasdaqGS:NYAX) from Market Perform to ...

William Blair reissued their market perform rating on shares of FibroGen (NASDAQ:FGEN – Free Report) in a research report ...

Palantir is poised to win a U.S. Army contract that could eventually deliver annual recurring revenue approaching $100 million, said a William Blair analyst.

KLP Kapitalforvaltning AS bought a new stake in Huron Consulting Group Inc. (NASDAQ:HURN – Free Report) during the fourth ...

William Blair China Growth Fund earns a Below Average Process Pillar rating. The process benefits from low costs across its parent firm's funds, whose fees rank in their respective category's ...